发明名称 2,7-NAPHTHYRIDINE DERIVATIVES
摘要 2,7-Naphthyridine containing squaric acids of formula (1) are described, wherein Ar<1> is an optionally substituted 2,7-naphthridin-1-yl group; L<2> is a covalent bond or a linker atom or group; Ar<2> is an optionally substituted aromatic or heteroaromatic chain; Alk is a chain (2) in which R is a carboxylic acid (-CO2H) or a derivative or biostere thereof; R<1> is a hydrogen atom or a C1-6alkyl group; L<1> is a covalent bond or a linker atom or group; Alk<1> is an optionally substituted aliphatic chain; n is zero or the integer 1; R<2> is a hydrogen atom or an optionally substituted heteroaliphatic, cycloaliphatic, heterocycloaliphatic, polycycloaliphatic, heteropolycycloaliphatic, aromatic or heteroaromatic group; and the salts, solvates, hydrates and N-oxides thereof. The compounds are able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells.
申请公布号 WO0192256(A1) 申请公布日期 2001.12.06
申请号 WO2001GB02425 申请日期 2001.05.30
申请人 CELLTECH R & D LIMITED;LANGHAM, BARRY, JOHN;ALEXANDER, RIKKI, PETER;HEAD, JOHN, CLIFFORD;LINSLEY, JANEEN, MARSHA;PORTER, JOHN, ROBERT;ARCHIBALD, SARAH, CATHERINE;WARRELLOW, GRAHAM, JOHN 发明人 LANGHAM, BARRY, JOHN;ALEXANDER, RIKKI, PETER;HEAD, JOHN, CLIFFORD;LINSLEY, JANEEN, MARSHA;PORTER, JOHN, ROBERT;ARCHIBALD, SARAH, CATHERINE;WARRELLOW, GRAHAM, JOHN
分类号 C07D487/08;A61K31/47;A61K31/4709;A61K31/5377;A61K31/541;A61K31/55;A61K31/551;A61P1/04;A61P3/10;A61P11/06;A61P17/06;A61P19/02;A61P25/28;A61P29/00;A61P37/00;A61P37/06;A61P43/00;C07D471/04;C07D519/00;(IPC1-7):C07D471/04;A61K31/435 主分类号 C07D487/08
代理机构 代理人
主权项
地址